Advertisement
At a meeting of the U.S. Food and Drug Administration vaccine advisory board

FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

0
Polls show Americans getting more skeptical about a vaccine, worry that approval process is being rushed
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 19 to 23

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
The majority of older women can tolerate surgery for operable breast cancer

Breast Cancer Surgery Feasible for Most Fit Older Women

0
Hormone therapy alone may be as good as surgery if life expectancy is less than four years
In a Society for Healthcare Epidemiology of America white paper

SHEA Updates Guidance for Health Care Staff With Hepatitis, HIV

0
Career counseling recommended for those planning to conduct exposure-prone procedures
Tocilizumab may be beneficial for adults with COVID-19 admitted to the intensive care unit

Findings Conflicted for Benefit of Tocilizumab in COVID-19

0
One trial shows reduction in mortality, but no evidence of efficacy seen in two additional trials
For patients with psoriasis

Survival From COVID-19 High in Patients With Psoriasis

0
Risk for hospitalization increased for patients using nonbiologic systemic therapy versus biologics
For patients with moderate COVID-19

Convalescent Plasma Has Limited Benefit for Moderate COVID-19

0
Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
Chemotherapy-free induction and consolidation first-line treatment with dasatinib and blinatumomab is associated with a high incidence of molecular response and survival in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

Dasatinib + Blinatumomab Active for Ph-Positive ALL in Adults

0
Complete remission, overall survival seen in 98, 95 percent of patients in phase 2 study
For women with breast cancer

Taking Lipid-Lowering Meds Tied to Lower Risk for Cancer Death

0
Adherence inversely linked to mortality related to breast cancer, CRC, melanoma in women
For moderately ill hospitalized patients with COVID-19

Tocilizumab Does Not Prevent Intubation, Death in COVID-19

0
Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients